Leewell Pharmaceuticals Private Limited
Leewell Pharmaceuticals Private Limited is a Private Company limited by Shares company incorporated in 2016 and based in Telangana, India. It was founded by Santosh. Leewell Pharmaceuticals Private Limited operates in Pharmaceuticals & Chemicals (NIC 24100) with authorized capital of ₹1.00 L and paid-up capital of ₹1.00 L. For 2018-19, the company reported revenue of ₹13.06 L and a net loss of ₹3.9K. RegisterKaro's Compliance Health Score for the company is 35/100 (grade F), reflecting a weak compliance posture.
Explore the complete profile of LEEWELL PHARMACEUTICALS PRIVATE LIMITED, including financials and company filings, contact details, and much more on Tracxn.
Quick facts
Directors
LockedDirectors, DINs & appointment history for Leewell Pharmaceuticals Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
MCA Filings
Locked| Form | FY | Filed | Due | Delay | Status |
|---|---|---|---|---|---|
| AOC-4 | FY2024-25 | 30 Oct 2024 | 30 Oct 2024 | 0d | filed |
| MGT-7 | FY2024-25 | 25 Nov 2024 | 29 Nov 2024 | 0d | filed |
| AOC-4 | FY2023-24 | 30 Oct 2023 | 30 Oct 2023 | 0d | filed |
| MGT-7 | FY2023-24 | 26 Nov 2023 | 29 Nov 2023 | 0d | filed |
| AOC-4 | FY2022-23 | 30 Oct 2022 | 30 Oct 2022 | 0d | filed |
| MGT-7 | FY2022-23 | 21 Nov 2022 | 29 Nov 2022 | 0d | filed |
Full MCA filing history for Leewell Pharmaceuticals Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Charges
Locked| Charge ID | Holder | Amount | Created | Status |
|---|---|---|---|---|
| 572620941 | ICICI Bank Ltd(Bank) | ₹3.65 Cr | 27 Jan 2022 | Open |
| 266383025 | Axis Bank Ltd(Bank) | ₹19.09 Cr | 19 Sep 2019 | Open |
| 789266454 | State Bank of India(Bank) | ₹7.88 Cr | 27 Jan 2021 | Open |
| 521991761 | Kotak Mahindra Bank Ltd(Bank) | ₹24.07 Cr | 27 Jan 2022 | Open |
| 682858443 | Kotak Mahindra Bank Ltd(Bank) | ₹18.97 Cr | 19 Sep 2021 | Open |
| 921793610 | Axis Bank Ltd(Bank) | ₹94.36 L | 04 Jul 2021 | Satisfied |
Charge IDs, lenders & amounts for Leewell Pharmaceuticals Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Financial Performance
MCA| FY | Revenue | PAT | Net Worth | Total Assets | Employees |
|---|---|---|---|---|---|
| 2018-19 | — | ||||
| 2017-18 | — | ||||
| 2016-17 | — |
Detailed Financials
3 FYs| Line item | 2018-19 | 2017-18 | 2016-17 |
|---|---|---|---|
| Income statement | |||
| Revenue from operations | |||
| Other income | |||
| Total income | |||
| Total expenses | |||
| Profit before tax | |||
| Profit / (Loss) after tax | |||
| Balance sheet | |||
| Equity / Net worth | |||
| Borrowings | |||
| Current liabilities | |||
| Total liabilities | |||
| Current assets | |||
| Cash & equivalents | |||
| Total assets | |||
| Employees | — | — | — |
Cash-flow statement renders when the AOC-4 XBRL Cash Flow context is parsed during the extract phase.
Compounded Annual Growth Rate
| Metric | Latest value | 1Y CAGR | 3Y CAGR | 5Y CAGR |
|---|---|---|---|---|
| Revenue2018-19 | +8.0% | — | — | |
| Profit after Tax2018-19 | — | — | — | |
| Net Worth2018-19 | -1.0% | — | — |
Financial Ratios
| FY | Revenue | PAT | PAT margin | Rev growth | ROE | ROA | D/E | Rev/emp |
|---|---|---|---|---|---|---|---|---|
| 2016-17 | +2.61% | — | +100.00% | +5.07% | 19.74 | |||
| 2017-18 | -0.42% | +79.16% | -4.47% | -1.41% | 3.18 | |||
| 2018-19 | -0.30% | +8.67% | -3.58% | -1.01% | 3.56 |
Cap Table & Shareholding
Locked| Category | Shareholders | Shares held | % |
|---|---|---|---|
| Promoters | 1 | 1,10,54,271 | 55.63% |
| Institutional Investors | 1 | 39,22,270 | 19.74% |
| Public & Others | 47 | 48,93,189 | 24.63% |
Promoter, institutional & public holding for Leewell Pharmaceuticals Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Peer Benchmark
343 peersEvents & timeline
3External data sources
7 plannedGSTIN Registrations
Per-state GSTINs + GSTR-1/3B filing cadence + turnover bracket. PAN-keyed scrape.
MSME Payment Delays
Half-yearly disclosure of payments delayed beyond 45 days to MSME suppliers.
Related Party Transactions
Counterparty, nature, transaction value. Inter-company loans, sales, royalty.
Credit Ratings
Long-term + short-term ratings, with rationale on rating actions.
Trademarks
Applied, registered, opposed. Class numbers + status.
Patents
Applications and grants. Inventor names + filing dates.
Legal Cases
Ongoing + past litigations the entity is party to.
Each source is wired as a separate ingestion adapter behind the scraper. Live status flips per CIN as records land.